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OBJECTIVE — To characterize glucose levels during daily living using continuous glucose
monitors (CGMs) in nondiabetic individuals.
RESEARCH DESIGN AND METHODS — Seventy-four healthy children, adolescents,
and adults aged 9–65 years with normal glucose tolerance used a blinded CGM device for 3 to
7 days.
RESULTS — Sensor glucose concentrations were 71–120 mg/dl for 91% of the day. Sensor
valueswere60or140mg/dlforonly0.2%and0.4%oftheday,respectively.Sensorglucose
concentrations were slightly higher in children than adults (P  0.009) and were slightly lower
during the night than day (95 vs. 99 mg/dl, P  0.001).
CONCLUSIONS — Glucose values 60 and 140 mg/dl, measured with CGM, are un-
common in healthy, nondiabetic individuals. CGM may be useful to evaluate glucose tolerance
innondiabeticindividualsovertime.Furthermore,thesedataprovideabasisforcomparisonfor
studies that use CGM to assess glucose control in subjects with diabetes.
Diabetes Care 33:1297–1299, 2010
C
ontinuousglucosemonitors(CGMs),
which measure interstitial glucose
concentrations,areincreasinglybe-
ing used in clinical practice and in clin-
ical research in patients with diabetes.
However, the variation in glucose levels
measured by CGM in healthy, nondia-
betic individuals during daily living has
notbeenextensivelystudied.Theaimof
this study was to characterize CGM glu-
cose patterns in healthy, nondiabetic
individuals.
RESEARCH DESIGN AND
METHODS— The study was con-
ducted at 10 adult and pediatric diabetes
centers, after approval by their institu-
tional review boards. Subjects were
healthy adults, adolescents, and children
who were clinic staff, friends, relatives of
clinic staff, or relatives or acquaintances
ofanindividualwithtype1diabetes.Sub-
jects provided written informed consent
and children gave assent to study partici-
pation. Inclusion criteria were: age 8
years old; BMI 10th to 90th percentile for
age and sex for subjects 18 years old
(based on 2000 Centers for Disease Con-
trol and Prevention (CDC) nomogram)
and 28 kg/m
2 for subjects 18 years
old; no signiﬁcant chronic illness or tak-
ing of any medications that might affect
glucose metabolism; A1C 6.0%; fasting
blood glucose 70 to 99 mg/dl; 2-h oral
glucosetolerancetest(OGTT)level140
mg/dl; and negative anti-GAD, anti-IA2,
and anti-insulin antibodies. Of 148 sub-
jects screened for the study, 39 were ex-
cluded because of low fasting glucose
(n3),elevatedfastingglucose(n16),
elevated 2-h glucose (n  5), positive an-
tibodies (n  8), ineligible BMI (n  3),
ineligibleA1C(n1),orinsufﬁcientsen-
sor data (n  3).
Subjects used either a Guardian Clin-
ical (n  38; Medtronic MiniMed,
Northridge, CA) for 3 days, a FreeStyle
Navigator (n  36; Abbott Diabetes Care,
Alameda, CA) for 5 days, or a DexCom
SEVEN (n  35, DexCom, San Diego,
CA) for 7 days. Subjects were instructed
oncalibrationofthedevicesusingahome
blood glucose meter. Results using the
DexCom sensor were not included in the
analysis because of the frequency of miss-
ing data because of overnight dropout of
sensor function, and because there was a
disproportionate number of low and high
glucose values compared with the other
sensors, which seemed unlikely to repre-
sent true extreme values in these nondia-
betic individuals. Notably, the current
commercially available DexCom device
contains newer software than the devices
usedinourstudy.Thediscrepanciesbe-
tweentheDexComresultsandtheother
two devices is shown in supplemental
Table A-1, available in an online appen-
dix at http://care.diabetesjournals.org/
cgi/content/full/dc09-1971/DC1.
Computed statistics included are
mean  SD for the glucose and medians
for the percentage of sensor glucose val-
ues in glucose ranges and glucose vari-
ability measures overall and in four age-
groups: 8 to 15, 15 to 25, 25 to 45,
and 45 years. The association of A1C,
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
Corresponding author: Roy W. Beck, jdrfapp@jaeb.org.
Received 26 October 2009 and accepted 25 February 2010. Published ahead of print at http://care.
diabetesjournals.org on 9 March 2010. DOI: 10.2337/dc09-1971.
*Alistofthewritingcommitteecanbefoundinthe APPENDIX,andacompletelistofthemembersofthestudy
group is included in the online appendix available at http://care.diabetesjournals.org/cgi/
content/full/dc09-1974/DC1.
Thestudywasdesignedandconductedbytheinvestigatorslistedintheappendix,whocollectivelywrotethe
manuscript and vouch for the data. The investigators had complete autonomy to analyze and report the
trial results. There were no agreements concerning conﬁdentiality of the data between the Juvenile
Diabetes Research Foundation, Inc., and the authors or their institutions. The Jaeb Center for Health
Research had full access to all of the data in the study and takes responsibility for the integrity of the data
and the accuracy of the data analysis.
© 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Emerging Treatments and Technologies
BRIEF REPORT
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 6, JUNE 2010 1297fasting blood glucose, and 2-h postpran-
dial blood glucose with age was assessed
using least-squares regression models.
The associations of mean sensor glucose
and glucose variability measures with age
were assessed using least-squares regres-
sionmodelsadjustingfordevicetype.The
repeated-measures regression models
were used to compare mean glucose and
glucose variability measures during day-
time versus nighttime, adjusting for de-
vice type and age. Rank scores were
transformed to have a normal distribu-
tion, using van der Waerden scores for
glucose variability measures because of
the skewed distributions. Regression
models of glucose variability measures
were adjusted for mean glucose as a
covariate.
RESULTS— The74subjectsrangedin
age from 9 to 65 years old. Of them, 51
(69%) were female; 55 (74%) were non-
Hispanic, Caucasian; 13 (18%) were His-
panic; 1 (1%) was African American; and
5 (7%) were other race/ethnicities. Mean
A1C ( SD) was 5.3  0.3% (range 4.7–
6.0%), fasting glucose was 86  8 mg/dl,
and 2-h post-OGTT was 96  22 mg/dl;
none of which varied meaningfully by
age.MedianBMIpercentilewas82nd(in-
terquartile range 62nd to 91st) for sub-
jects 18 years old (n  26) and median
BMI was 24.9 kg/m
2 (23.3, 26.3) for
those 18 years old (n  48).
CGM glucose values were obtained
for a mean of 84  21 h per subject. As
shown in Table 1, the mean sensor glu-
cose concentration was slightly higher
during the day (6:00 A.M. to midnight)
than during the night (midnight to 6:00
A.M., P  0.001 comparing day and
night). There was a slight association of
lower age and higher mean glucose level
(P  0.009), which was seen both during
the day (P  0.04) and overnight (P 
0.001) (Table 1; supplemental Figs. A-1
and A-2). Hourly means ranged from 92
mg/dlfrom5:00to6:00 A.M.to103mg/dl
from8:00to10:00 P.M.(supplementalﬁg-
ure A-2). The median percentage of sen-
sor values between 71 and 120 mg/dl was
91%, 0.2% of values being 60 mg/dl
and 0.4% 140 mg/dl; no subjects had
100% of values between 71 and 120
mg/dl (Table 1; supplemental Tables A-2
and A-3). Except for a slight tendency for
a higher rate of change in younger sub-
jects (P  0.04), other measures of glu-
cose variability were not inﬂuenced by
age (Table 1). Glucose variability was
lower at night than during the day (P 
0.001;Table1).Resultsweresimilarcom-
paring the Navigator and Guardian Clin-
ical CGM devices (mean glucose 98  11
and 98  9 mg/dl, respectively).
CONCLUSIONS — In this study we
havedescribedsensorglucoseproﬁlesus-
ing the Medtronic and Abbott Diabetes
CGM systems in healthy, anti–-cell an-
tibody–negative subjects across the spec-
trum of pediatric and adult age ranges.
Our mean sensor data were similar to
those reported in healthy Chinese sub-
jects using Medtronic’s Continuous Glu-
cose Monitoring System (1). However, in
that study, sensor values increased with
advancing age, contrary to our data, and
only subjects 20 years old were
included.
Our ﬁndings may be useful to clini-
cians and investigators who are using
these devices in patients with abnormal
Table 1—Sensor glucose values and glucose variability by age group and time of day
All
Age group Time of day
8–15 15–25 25–45 45 Daytime Nighttime
n 74 20 17 20 17
A1C (%) 5.3  0.3 5.3  0.2 5.2  0.2 5.2  0.3 5.5  0.3
Sensor glucose
Overall* 98  10 103  11 97  79 6  12 95  7
Daytime† 99  10 103  10 98  79 7  12 97  6
Nighttime‡ 95  13 101  15 97  11 91  12 89  11
Peak sensor glucose§
Daytime 131 134 135 125 128
Nighttime 109 111 111 104 103
Nadir sensor glucose§
Daytime 73 74 71 75 79
Nighttime 80 84 80 77 78
Distribution of sensor glucose levels
71–120 mg/dl 91.0% 85.1% 87.9% 91.4% 93.7% 90.4% 90.3%
70 mg/dl 1.7% 1.8% 0.6% 2.9% 1.6% 1.1% 2.2%
60 mg/dl 0.2% 0.2% 0.0% 0.2% 0.1% 0.0% 0.0%
120 mg/dl 5.6% 8.2% 8.3% 4.2% 4.4% 5.9% 1.1%
140 mg/dl 0.4% 1.3% 0.3% 0.3% 0.0% 0.5% 0.0%
Overall glucose variability
SD (mg/dl)  13.7 16.4 13.7 12.6 12.4 13.5 10.9
MARC (mg/dl/min)  0.34 0.36 0.34 0.32 0.33 0.37 0.26
Coefﬁcient of variation (%) ¶ 1 41 61 41 41 3 1 4 1 2
MAGE (mg/dl)  27.7 28.1 28.3 25.6 26.9 28.0 15.8
DataaremeansSDandmedians.*P0.009fortheassociationofmeanglucosewithage,adjustingfordevicetype.†P0.04fortheassociationofmeanglucose
with age, adjusting for device type. ‡P  0.001 for the association of mean glucose with age, adjusting for device type. §The calculation of peak and nadir glucose
was restricted to days with 12 h and nights with 4 h of glucose data.  P  0.001 for the association of glucose variability with time of day, adjusting for device
type and mean glucose. ¶Coefﬁcient of variation  SD/mean glucose. MARC, mean absolute rate of change; MAGE, mean amplitude of glycemic excursions.
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describe the frequency of out-of-range
sensor glucose values and the degree of
glucose variability that are likely to occur
in normoglycemic individuals. This pro-
vides a better understanding of what
constitutes biochemical hypo- or hyper-
glycemia reported by these devices.
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